Generic Drug Review Backlog Criticized At Appropriations Hearing
This article was originally published in The Pink Sheet Daily
Sen. Kohl (D-Wisc.) requests a report on FDA’s efforts to improve its generic approval process.
You may also be interested in...
GPhA says it would consider user fees for generics if FDA would endorse legislation to speed generics to the market.
The Lower PRICED Drugs Act from Sens. Lott (R-Miss.) and Stabenow (D-Mich.) also proposes to expand generic competition to non-“Orange Book”-listed antibiotics and to revise how 30-month stays are applied.
Amended application includes 50 mg and 100 mg dosage forms, which are used in multiple myeloma.